newsfilter
← Earnings
Earnings Releases·

Butterfly Network — Third Quarter 2026 Earnings Summary

  • Total revenue rose 52% year-over-year to $32.6 million, driven by a 71% surge in U.S. sales, while GAAP gross margin improved significantly to 73.0% from a 17.5% loss in the prior year.
  • Net loss narrowed to $12.8 million (EPS $(0.05)) from $34.0 million previously, with Adjusted EBITDA loss improving 85% to $1.2 million.
  • Full Year 2026 revenue guidance was raised to $123–$126 million (26–29% growth), and Adjusted EBITDA loss guidance increased to $12–$15 million; Q4 revenue is projected at $31–$34 million.
  • Strategic progress includes the commercial launch of Mendaera, FedRAMP authorization for federal pipeline access, and the addition of three new BCI partners, with next-gen P5.1 chip products scheduled for early 2027.
  • No M&A activity, capital returns, or dividend announcements were disclosed; cash and cash equivalents stood at $122.3 million as of September 30, 2026.
Company
BUTTERFLY NETWORK INC
Sector
Healthcare
Industry
Medical Devices